Hubei Sihuan Pharmaceutical

Hubei Sihuan Pharmaceutical Co., Ltd. is a Chinese pharmaceutical manufacturing company established in 2002 and based in Wuhan, Hubei Province. The company specializes in the production and development of chemical active pharmaceutical ingredients (APIs) and various solid dosage forms, including tablets, capsules, granules, and suppositories. Its commercial product portfolio features conventional medications such as trimetazidine hydrochloride for angina, rufloxacin hydrochloride for bacterial infections, ipriflavone for osteoporosis, and peramivir. Hubei Sihuan Pharmaceutical operates manufacturing facilities compliant with Good Manufacturing Practices (GMP) and serves as a key supplier of bulk chemicals and finished formulations in China.